Condition: Asthma
Interventions: Drug: MSTT1041A; Drug: Placebo
Sponsor: Hoffmann-La Roche
Recruiting – verified September 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma
Condition: Asthma
Intervention: Drug: VR588
Sponsors: Imperial College London; Vectura Limited
Recruiting – verified February 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)
Condition: Asthma
Interventions: Drug: MK-1029 150 mg; Drug: Placebo for MK-1029; Drug: Montelukast 10 mg; Drug: Albuterol/Salbutamol 90 mcg – 100 mcg per inhalation
Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting – verified March 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting
Condition: Asthma
Interventions: Drug: Lebrikizumab; Device: Prefilled Syringes
Sponsor: Hoffmann-La Roche
Not yet recruiting – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
Condition: Asthma
Intervention: Other: Laboratory biomarker analysis
Sponsor: Hoffmann-La Roche
Recruiting – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Percentage of participants have asthma exacerbations up to 2 years after … – Healio
|
Percentage of participants have asthma exacerbations up to 2 years after …
Healio “The current study suggests that the asthma exacerbation risk after stepping down asthma medication is similar to previous reports despite differences in patient selection, study setting and length of follow-up,” Matthew A. Rank, MD, of the Division of … |
View full post on asthma – Google News
A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Participants
Conditions: Dermatitis, Atopic; Asthma; Healthy
Intervention: Other: Allergic Skin Reaction (ASR) Testing and Skin Blister Induction
Sponsor: Janssen Research & Development, LLC
Not yet recruiting – verified January 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Condition: Asthma
Interventions: Biological: Mepolizumab; Drug: Placebo; Drug: SOC
Sponsor: GlaxoSmithKline
Not yet recruiting – verified October 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma
Conditions: Healthy; Asthma
Interventions: Drug: JNJ-43260295; Drug: Placebo; Other: Nasal Allergen Challenge
Sponsor: Janssen Research & Development, LLC
Not yet recruiting – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 5-11 Years Old With Persistent Asthma
Condition: Asthma
Interventions: Drug: Beclomethasone dipropionate; Drug: Placebo; Drug: albuterol/salbutamol 90 mcg
Sponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified January 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days